Ventas Inc <VTR.N>: BMO raises target price to $105 from $100
VTR•Related News
Monte Rosa Therapeutics Inc <GLUE.O>: Wedbush cuts target price to $27 from $37
GLUE•
AstraZeneca investors balk at $400 billion Bristol Myers tie-up reports
AZN•
Zevra publishes four-year real-world U.S. early access data on MIPLYFFA in Niemann-Pick disease type C
ZVRA•
BCB Bancorp posts Q2 net loss on higher credit costs
BCBP•
Compugen publishes corporate presentation on AI-driven immuno-oncology antibody pipeline
CGEN•